Literature DB >> 24113679

Issues related to overadherence to oral chemotherapy or targeted agents.

Sandra L Spoelstra1, Barbara A Given, Charles W Given, Marcia Grant, Alla Sikorskii, Mei You, Veronica Decker.   

Abstract

Use of oral chemotherapy or targeted agents is shifting how cancer treatment is administered, moving it from supervised office visits to self-administration at home. This study examines issues related to overadherence to oral agents that were noted during a trial conducted by the authors comparing an automated voice system to strategies to reduce symptom severity and improve adherence. Overadherence to oral agents may be a significant clinical problem, occurring more often in patients with complex dosing regimens, and may lead to increased symptom severity from side effects of treatment. Avoiding overadherence may be important for the reduction or prevention of symptoms and potentially life-threatening toxicity. Nurses need to discuss with their patients the importance of the timing of the administration of their oral oncolytic regimen, as well as to provide prompts to assist in self-administration as prescribed so that overadherence can be avoided.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24113679     DOI: 10.1188/13.CJON.17-06AP

Source DB:  PubMed          Journal:  Clin J Oncol Nurs        ISSN: 1092-1095            Impact factor:   1.027


  5 in total

1.  Self-Care Support for Patients with Gastrointestinal Cancer: iCancerHealth.

Authors:  Donna L Berry; Traci M Blonquist; Manan M Nayak; Nina Grenon; Thaer G Momani; Nadine J McCleary
Journal:  Appl Clin Inform       Date:  2018-11-21       Impact factor: 2.342

Review 2.  A Concept Analysis of Oral Anticancer Agent Self-management.

Authors:  Madilyn Mason; Marcelline R Harris; Joseph A Greer; Yun Jiang
Journal:  Cancer Nurs       Date:  2022 Mar-Apr 01       Impact factor: 2.592

3.  Inner conflict in patients receiving oral anticancer agents: a qualitative study.

Authors:  Kaori Yagasaki; Hiroko Komatsu; Tsunehiro Takahashi
Journal:  BMJ Open       Date:  2015-04-14       Impact factor: 2.692

4.  Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods.

Authors:  Aurélie Bourmaud; Emilie Henin; Fabien Tinquaut; Véronique Regnier; Chloé Hamant; Olivier Colomban; Benoit You; Florence Ranchon; Jérôme Guitton; Pascal Girard; Gilles Freyer; Michel Tod; Catherine Rioufol; Véronique Trillet-Lenoir; Franck Chauvin
Journal:  BMC Res Notes       Date:  2015-07-04

5.  Treatment Experiences with CDK4&6 Inhibitors Among Women with Metastatic Breast Cancer: A Qualitative Study.

Authors:  Judith J Stephenson; Jonathon Colby Gable; Rebekah Zincavage; Gregory L Price; Collin Churchill; Emily Zhu; Keri Stenger; Mukul Singhal; Bal Nepal; Michael Grabner; Michael J Fisch; David Debono; Amy R Geschwender; Gebra Cuyun Carter
Journal:  Patient Prefer Adherence       Date:  2021-11-03       Impact factor: 2.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.